Received Jun 29, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RAB | RABIES (RABAVERT) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | Unknown | — |
Rabavert was administered by a nurse to a patient and there was about 0.5ml of air bubble, it might be a little less, but there was obvious air in the vaccine; Rabavert was administered by a nurse to a patient and there was about 0.5ml of air bubble, it might be a little less, but there was obvious air in the vaccine; Case reference number US-BN-2026-000093 is a spontaneous case initially received from other health professional via Bavarian Nordic (reference number: CASE-001631) on 16-Jan-2026 and concerns a patient of an unknown age and gender. The patient's medical history and concomitant medication details were not provided. ~ On an unspecified date, the patient received a dose of RabAvert along with its constituent parts prefilled syringe, needle for injection and needle for reconstitution (batch number: unknown), at an unknown dose, site or route of administration for unknown indication and there was about 0.5ml of air, it might be a little less, but there was obvious air in the vaccine (explicitly coded as 'bubbles present in liquid product,' and 'product administration error'). At the time of initial, it was unknown if the patient experienced any adverse event due to the RabAvert vaccination. No further information was provided.; Reporter's Comments: A patient of an unknown age and gender received a dose of RabAvert for unknown indication and there was about 0.5ml of air, it might be a little less, but there was obvious air in the vaccine, which is considered as bubbles present in liquid product and product administration error. It was unknown if the patient experienced any adverse event due to the RabAvert vaccination. Liquid product physical issue and product administration error are considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Liquid product physical issue and product administration error are not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: A patient of an unknown age and gender received a dose of RabAvert for unknown indication and there was about 0.5ml of air, it might be a little less, but there was obvious air in the vaccine, which is considered as bubbles present in liquid product and product administration error. It was unknown if the patient experienced any adverse event due to the RabAvert vaccination. Liquid product physical issue and product administration error are considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Liquid product physical issue and product administration error are not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.
Comments: None.